Abstract：Objective: To investigate the status of rationality in perioperative use of antibacterials in patients undergoing type Ⅰ incision operation in a hospital, and to discuss the ways to improve the rational use of antibiotics during the perioperative period. Methods: The perioperative data of 1,023 patients undergoing type Ⅰ incision operation in our hospital from December 2016 to December 2017 were retrospectively analyzed. The preventive medication and rational administration were analyzed. Results: In the perioperative period of type I incision, 436 patients (42.62%) were treated with antibacterial drugs, and the preventive use rate of neurosurgical antibiotics was 93.25%, which was higher than other departments. In the selection of antibacterial drugs, the use rate of etimicin was the highest, accounting for 16.81%, followed by cefamandole and piperacillin and sulbactam, accounting for 16.23% and 11.63%, respectively; The timing of drug administration in 387 cases was 0.5 to 2 hours before operation, accounting for 88.76%. In 219 cases, the course of treatment with antimicrobial agents was <24 hours, accounting for 50.22%; The reasonable rates of indications for drug use, variety selection, timing of administration, dosage, administration route, drug type, dosing duration, and combination use were 73.85%, 16.28%, 88.76%, 73.62%, 98.17%, and 86.93%, respectively. 50.22%, 97.48%. Conclusion: In our hospital, the use rate of antibiotics for patients undergoing type Ⅰ incision operation is high, but the reasonable rate is low, moreover, the reasonable rate of selection and administration of the drug is particularly low, so the management of antibacterial drugs and the rationalization of the use of antibacterial drugs during the perioperative period of physicians should be strengthened.
严江, 徐飞, 王萍, 陈立波, 吴雯雯. 我院Ⅰ类切口手术围术期抗菌药物的合理用药评价现状研究[J]. 河北医学, 2019, 25(1): 115-118.
YAN Jiang, XU Fei, WANG Ping, et al. Evaluation of Rational Use of Antibiotics in Perioperative Period of Class I Incision Surgery in Our Hospital. HeBei Med, 2019, 25(1): 115-118.
[1] 张小丹,杨峰,潘春晓,等.肿瘤专科医院960例Ⅰ类切口手术围手术期抗菌药物预防性使用点评分析[J].中国药师,2015,18(11):1922~1925. [2] Chan S A, Agh W, Stembridge N, et al. Do perioperative antibiotics reduce the risk of surgical-site infections following excision of ulcerated skin cancers:a critically appraised topic[J]. British Journal of Dermatology, 2017, 178(2):159. [3] 王向荣,徐晓琳,李忠东,等.3种Ⅰ类切口手术预防性应用抗菌药物个体化量化点评方法的探讨[J].药学服务与研究,2016,16(3):175~179. [4] Kamradt M, Kaufmannkolle P, Andres E, et al. Sustainable reduction of antibiotic-induced antimicrobial resistance (ARena) in German ambulatory care: study protocol of a cluster randomised trial[J]. Implementation Science, 2018, 13(1):23. [5] 李慧兰,朱苗苗,张佩,等.某"三甲"医院Ⅰ类切口手术围术期预防使用抗菌药物调查分析[J].中国药房,2016,27(8):1030~1032. [6] 史庆丰,张尧,孙伟,等.2013-2016年上海市86所医院Ⅰ类切口围术期抗菌药物预防应用调查分析[J].中华医院感染学杂志,2017,27(24):5604~5607. [7] 冒群,徐爱宁.某医院2016年Ⅱ类切口围手术期预防性应用抗菌药物的合理性分析[J].解放军预防医学杂志,2017,30(10):1301~1303. [8] 邱刚,赵颖斐,张林祥,等.某县级医院外科清洁切口手术围手术期预防使用抗菌药物情况调查[J].中国消毒学杂志,2016,33(5):443~445. [9] Huang J, Wang X, Chen X, et al. Perioperative antibiotics to prevent acute endophthalmitis after ophthalmic surgery: a systematic review and meta-analysis[J]. Plos One, 2016, 11(11):141. [10] 张芳,沈绍清,李外,等.2016年解放军总医院海南分院Ⅰ类切口围手术期抗菌药物预防使用情况分析[J].现代药物与临床,2017,32(11):2257~2261. [11] 王烨菁,高淑娜,何丽华,等.2007-2013年上海市黄浦区居民吸烟、戒烟及被动吸烟状况变化趋势[J].环境与职业医学,2016,33(5):471~474. [12] 张华,朱亮,乔鹏.抗菌药物管理对Ⅰ类切口手术围手术期抗菌药物使用合理性的影响[J].贵州医药,2017,41(11):1193~1195. [13] 潘京京,孙萌,王惠川,等.西安市14所医院Ⅰ类手术切口抗菌药物预防性应用分析[J].中华医院感染学杂志,2016,26(6):1397~1399. [14] 王绚,许静,徐进.我院2014年Ⅰ类切口手术围术期抗菌药物预防应用分析[J].儿科药学杂志,2016,22(11):32~35.
2019, Vol. 25 
冀公网安备13080202000677号